Pernix Therapeutics Holdings Inc (PTX)

0.58
0.00 0.75
NASDAQ : Health Care
Prev Close 0.58
Open 0.59
Day Low/High 0.57 / 0.60
52 Wk Low/High 0.39 / 5.60
Volume 1.24M
Avg Volume 5.82M
Exchange NASDAQ
Shares Outstanding 85.12M
Market Cap 51.92M
EPS -2.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Pernix Therapeutics Announces The Issuance Of Two New Orange Book Listed Patents For Zohydro® ER With BeadTek™

Pernix Therapeutics Announces The Issuance Of Two New Orange Book Listed Patents For Zohydro® ER With BeadTek™

Patents cover important safety information related to dosing patients

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under-$10 stocks look ready to break out and trade higher from current levels.

These 5 Stocks Are Breaking Out

These 5 Stocks Are Breaking Out

Here's a technical look at how to trade five stocks that look poised to break out and trade higher from current levels.

Pernix Therapeutics Announces Restructuring  of Sales Force And Operations

Pernix Therapeutics Announces Restructuring  of Sales Force And Operations

Reorganization Expected to Drive Long-Term Revenue Growth, Improve Profitability and Result in Annualized Cost Savings of Approximately $10 Million

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These under -$10 stocks are poised to breakout and trade higher from current levels.

Today's Weak On High Volume Stock: Pernix Therapeutics Holdings (PTX)

Today's Weak On High Volume Stock: Pernix Therapeutics Holdings (PTX)

Trade-Ideas LLC identified Pernix Therapeutics Holdings (PTX) as a weak on high relative volume candidate

Pernix Therapeutics Announces The Issuance Of Three New Orange Book Patents For Zohydro® ER With BeadTek™

Pernix Therapeutics Announces The Issuance Of Three New Orange Book Patents For Zohydro® ER With BeadTek™

Patents cover important safety information related to dosing patients who are prescribed Zohydro® ER (hydrocodone bitartrate) Extended-Release Capsules with BeadTek™

Pernix Therapeutics Holdings (PTX) Highlighted As Weak On High Volume

Pernix Therapeutics Holdings (PTX) Highlighted As Weak On High Volume

Trade-Ideas LLC identified Pernix Therapeutics Holdings (PTX) as a weak on high relative volume candidate

Pernix Therapeutics Holdings (PTX) Is Strong On High Volume Today

Pernix Therapeutics Holdings (PTX) Is Strong On High Volume Today

Trade-Ideas LLC identified Pernix Therapeutics Holdings (PTX) as a strong on high relative volume candidate

Pernix Therapeutics Announces CEO Transition

Pernix Therapeutics Announces CEO Transition

Director John Sedor Appointed Interim CEO and Chairman

Strong On High Relative Volume: Pernix Therapeutics Holdings (PTX)

Strong On High Relative Volume: Pernix Therapeutics Holdings (PTX)

Trade-Ideas LLC identified Pernix Therapeutics Holdings (PTX) as a strong on high relative volume candidate

Pernix Therapeutics Holdings (PTX) Stock: Weak On High Volume Today

Pernix Therapeutics Holdings (PTX) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Pernix Therapeutics Holdings (PTX) as a weak on high relative volume candidate

These 5 Under-$10 Stocks Are Set to Soar Higher

These 5 Under-$10 Stocks Are Set to Soar Higher

These under-$10 stocks look poised to break out and trade higher from current levels.

6 Biotech Stocks Under $10 to Trade for Big Breakouts

6 Biotech Stocks Under $10 to Trade for Big Breakouts

These stocks trading for less than $10 a share are within range of triggering big breakout trades.

Pernix Therapeutics Files Citizen Petition Following Issuance Of U.S. Patent Number 9,265,760 ('760 Patent) Covering Safety Information Related To Dosing Patients With Zohydro ER® With BeadTek™ CII

Pernix Therapeutics Files Citizen Petition Following Issuance Of U.S. Patent Number 9,265,760 ('760 Patent) Covering Safety Information Related To Dosing Patients With Zohydro ER® With BeadTek™ CII

Pernix Therapeutics Holdings, Inc. files a Citizen Petition requesting the FDA refrain from approving any application for Generic Zohydro ER that proposes to omit from labeling important safety information protected by the '760 patent.

Pernix Therapeutics Announces The Issuance Of New Orange Book Patent For Zohydro® ER With BeadTek™ CII

Pernix Therapeutics Announces The Issuance Of New Orange Book Patent For Zohydro® ER With BeadTek™ CII

Pernix Announces the Issuance of U.S. Patent Number 9,265,760 Covering Important Safety Information Related to Dosing Patients Who Are Prescribed Zohydro® ER (Hydrocodone Bitartrate) Extended-Release Capsules with BeadTek.